T2 Biosystems Profit Margin 2013-2018 | TTOO
Current and historical gross margin, operating margin and net profit margin for T2 Biosystems (TTOO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. T2 Biosystems net profit margin as of December 31, 2018 is -487.17%.
|T2 Biosystems Annual Profit Margins
|T2 Biosystems Quarterly Profit Margins
||Medical Instruments Manufacturing
T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.